Biological products sector fluctuated and rebounded, Wanze shares reached the limit up.

The biopharmaceutical sector fluctuated and rebounded, Wanze Stock rose by its daily limit, Nuojilan increased by over 13%, Nuoweizan, Baike Biotechnology, Kexing Pharmaceutical, and others followed the upward trend.